Remimazolam Anesthesia for a Pediatric Patient With Glutaric Aciduria Type I: A Case Report
- PMID: 39258041
- PMCID: PMC11386074
- DOI: 10.7759/cureus.66612
Remimazolam Anesthesia for a Pediatric Patient With Glutaric Aciduria Type I: A Case Report
Abstract
Glutaric aciduria type I (GA-1) is a rare metabolic disorder caused by an autosomal, recessive, inherited deficiency of glutaryl-CoA dehydrogenase. Reports on the anesthetic management of patients with GA-1 are limited. It has been suggested that inhalation anesthesia is safer than propofol due to the mitochondrial dysfunction inherent in GA-1. However, inhalation anesthesia poses a risk, albeit rare, of malignant hyperthermia, which can result in severe neurological damage in GA-1 patients. Therefore, we considered that management using remimazolam might be effective and, provided a successful general anesthesia using it for a pediatric patient with GA-1. We report a case of a four-year-old girl with GA-1 who underwent a laparoscopic gastrostomy under general anesthesia. Remimazolam was used for both induction and maintenance of anesthesia. Our perioperative management also included measures to prevent a hypercatabolic condition such as adequate hydration and blood glucose control. The patient had an uneventful perioperative course and was discharged on postoperative day 7. Thus, remimazolam is proposed as a new option for anesthetic management in patients with GA-1. Additionally, tailored perioperative management that addresses the unique characteristics of GA-1 is crucial for favorable outcomes.
Keywords: general anesthesia; glutaric aciduria type 1; mitochondrial disorder; perioperative management; remimazolam.
Copyright © 2024, Tsuruno et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


References
-
- Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: third revision. Boy N, Mühlhausen C, Maier EM, et al. J Inherit Metab Dis. 2023;46:482–519. - PubMed
-
- Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Kölker S, Garbade SF, Greenberg CR, et al. Pediatr Res. 2006;59:840–847. - PubMed
-
- The child with glutaric aciduria type I: anesthetic and perioperative management. Tsiotou AG, Malisiova A, Bouzelos N, Velegrakis D. J Anesth. 2011;25:301–304. - PubMed
-
- Anesthetic management of comprehensive dental restoration in a child with glutaric aciduria type 1 using volatile sevoflurane. Teng WN, Lin SM, Niu DM, Kuo YM, Chan KH, Sung CS. J Chin Med Assoc. 2014;77:548–551. - PubMed
Publication types
LinkOut - more resources
Full Text Sources